Jim Jingjun Huang
Ascendia Pharmaceuticals, USA
Biography
Jim Jingjun Huang has Founded Ascendia Pharmaceuticals in the year 2012 after 15 years of Pharmaceutical R&D and Management experience at Pfizer, Baxter, AstraZeneca and Roche. He has led the formulation development efforts for the successful transition of several oral and parenteral dosage forms from discovery through formulation, manufacturing, technical transfer and ultimately commercialization. He holds a PhD in Pharmaceutics from the University of the Sciences in Philadelphia (formerly Philadelphia College of Pharmacy and Sciences) where he worked with Joseph B Schwartz. His research interests are centered on improvement of solubility and dissolution, and controlled delivery of poorly water soluble drugs through Nano-emulsion and Amorphous Solid Dispersion Technologies. He has been a Reviewer for the Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics, Journal of Controlled Release, Drug Development and Industrial Pharmacy, PDA Journal of Pharmaceutical Science and Technology, Molecular Pharmaceutics and Pharmaceutical Research. Currently, he is a Member of American Association of Pharmaceutical Scientists (AAPS) and American Chemical Society (ACS).
Abstract
Abstract : Parenteral drug delivery systems for insoluble drugs